Novartis AG Common Stock (NVS)

Investing Cash Flow

-$17.80B

TTM · Period ending: · USD

NVS logo

NVS Investing Cash Flow

Latest reported-$17.80B
NVS TTM Cash from Investing (-$1.30B → -$17.80B)
High-resolution chart · PNG

NVS investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novartis AG Common Stock Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-17,797,568,814
-16,950,178,114
-4,884,178,114
-5,806,000,000
-5,320,000,000
-6,284,000,000
-7,513,000,000
-5,592,000,000
-8,078,000,000
-5,924,000,000
5,596,000,000
5,241,000,000
13,299,000,000
2,724,000,000
1,468,000,000
7,498,000,000
1,068,000,000
12,793,000,000
4,208,000,000
-926,000,000
-1,739,000,000
-2,261,000,000
-13,182,000,000
-12,293,000,000
-13,646,000,000
-13,695,000,000
-2,226,000,000
-7,479,000,000
-4,967,000,000
-168,000,000
-5,591,000,000
-1,652,000,000
-1,451,000,000
-6,113,000,000
-3,119,000,000
-3,196,000,000
-3,263,000,000
-3,770,000,000
-3,441,000,000
-4,058,000,000
-4,059,000,000
-4,999,000,000
-10,784,000,000
-10,013,000,000
-9,206,000,000
-8,500,000,000
880,000,000
-856,000,000
-1,663,000,000
-1,225,000,000
-3,352,000,000
-3,233,000,000
-4,451,000,000
-4,534,000,000
-5,675,000,000
-3,963,000,000
-2,561,000,000
-1,728,000,000
-792,000,000
-555,000,000
-10,648,000,000
-14,129,000,000
-15,756,000,000
-19,362,000,000
-13,152,000,000
-12,513,000,000
-14,219,000,000
-11,755,000,000
-20,426,000,000
-16,643,000,000
-10,367,000,000
-10,319,000,000
216,000,000
-1,560,000,000
-6,244,000,000
-5,397,000,000
-3,289,000,000
-7,584,000,000
-6,575,000,000
-7,046,000,000
-9,898,000,000
-10,126,000,000
-7,482,000,000
-5,917,000,000
-4,155,000,000
473,000,000
-3,219,000,000
-3,814,000,000
-3,169,000,000
-2,535,000,000
-1,298,000,000
-2,077,000,000
382,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.